Last reviewed · How we verify

Gebauer's Ethyl Chloride Topical Spray

University of California, Davis · Phase 1 active Small molecule Quality 0/100

Gebauer's Ethyl Chloride Topical Spray is a Small molecule drug developed by University of California, Davis. It is currently in Phase 1 development.

At a glance

Generic nameGebauer's Ethyl Chloride Topical Spray
SponsorUniversity of California, Davis
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Gebauer's Ethyl Chloride Topical Spray

What is Gebauer's Ethyl Chloride Topical Spray?

Gebauer's Ethyl Chloride Topical Spray is a Small molecule drug developed by University of California, Davis.

Who makes Gebauer's Ethyl Chloride Topical Spray?

Gebauer's Ethyl Chloride Topical Spray is developed by University of California, Davis (see full University of California, Davis pipeline at /company/university-of-california-davis).

What development phase is Gebauer's Ethyl Chloride Topical Spray in?

Gebauer's Ethyl Chloride Topical Spray is in Phase 1.

Related